IDRA - Idera Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5393.23M
Enterprise Value 3265.16M
Trailing P/E N/A
Forward P/E 1-4.37
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)435.95
Price/Book (mrq)3.65
Enterprise Value/Revenue 3293.96
Enterprise Value/EBITDA 6-4.41

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin 0.00%
Operating Margin (ttm)-6,750.55%

Management Effectiveness

Return on Assets (ttm)-32.86%
Return on Equity (ttm)-62.53%

Income Statement

Revenue (ttm)902k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-98.90%
Gross Profit (ttm)902k
EBITDA -60.14M
Net Income Avi to Common (ttm)-65.98M
Diluted EPS (ttm)-0.42
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)112.63M
Total Cash Per Share (mrq)0.58
Total Debt (mrq)209k
Total Debt/Equity (mrq)0.19
Current Ratio (mrq)11.54
Book Value Per Share (mrq)0.55

Cash Flow Statement

Operating Cash Flow (ttm)-55.26M
Levered Free Cash Flow (ttm)-27.8M

Trading Information

Stock Price History

Beta 1.69
52-Week Change 3-20.25%
S&P500 52-Week Change 315.81%
52 Week High 32.87
52 Week Low 31.32
50-Day Moving Average 31.92
200-Day Moving Average 32.08

Share Statistics

Avg Vol (3 month) 31.79M
Avg Vol (10 day) 31.06M
Shares Outstanding 5195.64M
Float 155.14M
% Held by Insiders 114.89%
% Held by Institutions 137.00%
Shares Short 34.51M
Short Ratio 31.11
Short % of Float 33.04%
Shares Short (prior month) 33.06M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/8
Last Split Date 3Jun 30, 2006